Ledger.Open graph →
SEC Form D · filed February 14, 2019

Recros Medica, Inc

Offering
$10.0M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Thomas A. Albright · San Diego, CAExec · DirectorRandall Lunn · LAGUNA HILLS, CAExecKathleen D. Scott · San Diego, CAExecMilind K. Ambe, M.D · San Diego, CADirectorChristoph J. Westphal · San Diego, CADirectorJohn L. Hadl · Los Angeles, CADirectorMark J. Kerslake · San Diego, CADirectorChristoph J. Westphal · San Diego, CADirectorAndrew Mills · ALISO VIEJO, CADirectorMark J. Kerslake · San Diego, CADirectorObvious Ventures Management Ii, L.L.C · SAN FRANCISCO, CADirectorDavid F. Hale · San Diego, CADirectorMark Padley · NEW YORK, NYExecWilliam J. Leigh · Seattle, WADirectorEdward F. Knowlton, M.D · San Diego, CAExec · DirectorBernard P. Murphy · Seattle, WAExec · DirectorThomas J. Furphy · Sammamish, WAExec · DirectorCathy L. Mccarthy · San Diego, CADirectorSirjang Tandon · SIMI VALLEY, CADirectorThomas A. Albright · San Diego, CAExec · DirectorGregory N. Martin · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗